VTL Vital Therapies, Inc. gains 17% Dec 28, 2017

Vital Therapies, Inc., a biotherapeutic company, focuses on developing a human hepatic cell-based therapy targeting the treatment of acute forms of liver failure in the United States. Its ELAD system is an extracorporeal human allogeneic cellular liver therapy that is in Phase III clinical trials to allow the patient's own liver to potentially regenerate to a healthy state or to stabilize the patient until transplant. The company was formerly known as Vitagen Acquisition Corp. and changed its name to Vital Therapies, Inc. in June 2003. Vital Therapies, Inc. was founded in 2003 and is headquartered in San Diego, California. http://www.priceseries.com/trade/VTL-Vital-Therapies-Inc-stock-gains-17-percent-a-Trade-Record-by-priceSeries-2017121120171228.html